drugset / Trial / NCT01379326
Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2
Phase 4
Completed
250 enrolled
University Ghent
Commonwealth Scientific and Industrial Research Organisation, Australia · collabFundación Huésped · collabInstitut Pasteur · collabInstitut Pasteur, Cambodia · collabIvo de Carneri, Pemba Island, Tanzania · collabJimma University · collabNational Institute of Malariology, Parasitology and Entomology, Vietnam · collabOswaldo Cruz Foundation · collabQueensland Institute of Medical Research · collabThe University of Queensland · collabUniversity of Nottingham · collabUniversity of Yaounde 1 · collabWorld Health Organization · collab
NaSingle-groupOpen-labelTreatment
Summary
Objectives: The overall objective is to monitor efficacy of mebendazole (MBZ) against Soil-Transmitted Helminths (STH). The primary objective is: (1) to monitor the efficacy a single dose 500 mg of mebendazole (MBZ) against Soil-Transmitted Helminths (STH) infections by means of Faecal Egg Count Reduction (FECR) and Cure Rate (CR). The secondary objectives are: 1. to assess the occurrence of Necator americanus and Ancylostoma duodenal. 2. to assess the occurrence of β-tubulin mutations related to resistance before and after drug administration. 3. to evaluate the role of dogs and pigs as reservoir for zoonotic transmission.
Timeline
- Start
- 2011-12
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mebendazole | Small molecule | 500 mg | Oral |